Pediatr. praxi. 2012;13(3):149-152

Primary immunodeficiencies in children, current therapeutic options

MUDr.Pavel Rozsíval1,2, doc.MUDr.Eva Pařízková, CSc.1,2, MUDr.Pavlína Králíčková3
1 Dětská klinika, FN Hradec Králové
2 Katedra pediatrie, Lékařská fakulta UK v Hradci Králové
3 Ústav klinické imunologie a alergologie, FN Hradec Králové

Authors present an overview of current therapeutic possibilities of primary immunodeficiencies in children. The largest part is devoted

to antimicrobial therapy and antibody substitution, which are the most common procedures encountered by primary pediatricians.

Keywords: primary immunodeficiencies, antibody substitution, chemoprophylaxis, vaccination

Published: June 18, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rozsíval P, Pařízková E, Králíčková P. Primary immunodeficiencies in children, current therapeutic options. Pediatr. praxi. 2012;13(3):149-152.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lozovaya N, Miller AD. Chemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems. Chembiochem, 2003; 4(6): 466-484. Go to original source... Go to PubMed...
    2. Notarangelo LD, Fischer A, Geha RS, et al. Primary immunodeficiencies: 2009 update: The International Union of Immunological Societies (IUIS) Primary Immunodeficiencies (PID) Expert Committee. J Allergy Clin Immunol 2009; 124(6): 1161-1178. Go to original source... Go to PubMed...
    3. ESID: Diagnostic criteria for PID http://www.esid.org/clinical-diagnostic-criteria-for-pid-73-0 a Jeffrey Modell Foundation: Specific defects http://www.info4pi.org/aboutPI/index. cfm? section=aboutPI&content=defects&CFID=624251&CFTOKEN=19570899.
    4. de Vries E, Clinical Working Party of the European Society for Immunodeficiencies (2006). Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol 145: 204-214. Go to original source... Go to PubMed...
    5. 10 Warning Signs of PID - General: http://www.esid.org/clinical-10-warning-signs-of-pid-general-339-0.
    6. PID Awareness in East-Central Europe - J Project: http://www.esid.org/pid-care-pid-awareness-in-east-central-europe-j-project-36-0.
    7. Stiehm ER, Ochs HD, Winkelstein JA. Immunologic disorders in infants and children. 5. vyd. Philadelphia: Elsevier, 2004: 331.
    8. Cant AJ. Vaccination in Primary Immunodeficiency. http://www.ipopi.org/uploads/media/PastEvents/presentations/PID_and_Vaccines_Oct_2010.pdf.
    9. Lucas M, Lee M, Lortan J, et al. Infection outcomes in patiens with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010; 125: 1354-1360. Go to original source... Go to PubMed...
    10. Stiehm ER, Ochs HD, Winkelstein JA. Immunologic disorders in infants and children. 5. vyd. Philadelphia: Elsevier, 2004: 332-342.
    11. Wimperis J, Lunn M, Jones A, et al. (Second Edition Update Working Group). Clinical Guidelines for Immunoglobulin Use. Second Edition Update. 2011. http://www.ivig.nhs.uk/documents/dh_129666.pdf.
    12. Porta F, Forino C, De Martiis D, et al. Stem cell transplantation for primary immunodeficiencies. Bone Marrow Transplantation 2008; 41: S83-S86. Go to original source... Go to PubMed...
    13. Bartůňková J. Imunodeficience. Praha: Grada Publishing, 2002: 82.
    14. Aiuti A, Roncarolo MG. Ten years of gene therapy for primary immune deficiencies. Hematology Am Soc Hematom Educ Program 2009: 682-689. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.